Policy changes that expanded enrollment in Medicaid and Health Exchange plans are at risk. Precision’s Cynthia Miller and Maureen Hennessey discuss why discontinuing the policy changes will contribute to health inequities in myriad ways, and identify the essential role pharmaceutical companies can play in mitigating the impact.
